Melatonin supplementation during controlled ovarian stimulation for women undergoing assisted reproductive technology: systematic review and meta-analysis of randomized controlled trials


      To examine the best evidence available regarding the effect of melatonin supplementation during controlled ovarian stimulation (COS) on the main assisted reproductive technology (ART) outcomes.


      Systematic review and meta-analysis of randomized clinical trials (RCT).


      Not applicable.


      Women undergoing COS for ART.


      Melatonin supplementation during COS for women undergoing ART.

      Main Outcome Measure(s)

      Live birth rate, clinical pregnancy rate, number of retrieved oocytes, miscarriage rate, ovarian hyperstimulation syndrome (OHSS) rate, and number of congenital abnormalities. Comparisons were performed using risk ratio (RR) or mean difference (MD).


      Five RCTs were considered eligible, and their data were extracted and included in a meta-analysis. No studies reported live-birth or congenital abnormalities. Our estimates were imprecise for distinguishing between no effect and benefit considering clinical pregnancy (RR, 1.21; 95% confidence interval [CI], 0.98–1.50, five studies, 680 women, low quality-evidence) and the number of oocytes retrieved (MD, 0.6; 95% CI, −0.2–2.2, five studies, 680 women, low quality-evidence). Our estimates were imprecise for distinguishing among harm, no effect, and benefit considering miscarriage (RR, 1.07; 95% CI, 0.43–2.68, two studies, 143 clinical pregnancies, low quality-evidence) and interventions to reduce the risk of OHSS (RR,1.01; 95% CI, 0.33–3.08, one study, 358 women, low quality-evidence).


      More studies investigating the role of melatonin supplementation are still needed before recommending its use in clinical practice.

      Key Words

      To read this article in full you will need to make a payment


        • Gnoth C.
        • Godehardt E.
        • Frank-Herrmann P.
        • Friol K.
        • Tigges J.
        • Freundl G.
        Definition and prevalence of subfertility and infertility.
        Hum Reprod. 2005; 20: 1144-1147
        • Thoma M.E.
        • McLain A.C.
        • Louis J.F.
        • King R.B.
        • Trumble A.C.
        • Sundaram R.
        • et al.
        Prevalence of infertility in the United States as estimated by the current duration approach and a traditional constructed approach.
        Fertil Steril. 2013; 99: 1324-1331.e1
        • Bushnik T.
        • Cook J.L.
        • Yuzpe A.A.
        • Tough S.
        • Collins J.
        Estimating the prevalence of infertility in Canada.
        Hum Reprod. 2012; 27: 738-746
        • Zegers-Hochschild F.
        • Adamson G.D.
        • de Mouzon J.
        • Ishihara O.
        • Mansour R.
        • Nygren K.
        • et al.
        The International Committee for Monitoring Assisted Reproductive Technology (ICMART) and the World Health Organization (WHO) Revised Glossary on ART Terminology, 2009.
        Hum Reprod. 2009; 24: 2683-2687
        • Gunby J.
        • Bissonnette F.
        • Librach C.
        • Cowan L.
        Assisted reproductive technologies (ART) in Canada: 2007 results from the Canadian ART Register.
        Fertil Steril. 2011; 95: 542-547.e1–10
        • Nastri C.O.
        • Gibreel A.
        • Raine-Fenning N.
        • Maheshwari A.
        • Ferriani R.A.
        • Bhattacharya S.
        • et al.
        Endometrial injury in women undergoing assisted reproductive techniques.
        Cochrane Database Syst Rev. 2012; 7: CD009517
        • Martins W.P.
        • Rocha I.A.
        • Ferriani R.A.
        • Nastri C.O.
        Assisted hatching of human embryos: a systematic review and meta-analysis of randomized controlled trials.
        Hum Reprod Update. 2011; 17: 438-453
        • Teixeira D.M.
        • Barbosa M.A.
        • Ferriani R.A.
        • Navarro P.A.
        • Raine-Fenning N.
        • Nastri C.O.
        • et al.
        Regular (ICSI) versus ultra-high magnification (IMSI) sperm selection for assisted reproduction.
        Cochrane Database Syst Rev. 2013; 7: CD010167
        • Agarwal A.
        • Gupta S.
        • Sharma R.K.
        Role of oxidative stress in female reproduction.
        Reprod Biol Endocrinol. 2005; 3: 28
        • Gupta S.
        • Agarwal A.
        • Banerjee J.
        • Alvarez J.G.
        The role of oxidative stress in spontaneous abortion and recurrent pregnancy loss: a systematic review.
        Obstet Gynecol Surv. 2007; 62 (quiz 53–54): 335-347
        • Carlomagno G.
        • Nordio M.
        • Chiu T.T.
        • Unfer V.
        Contribution of myo-inositol and melatonin to human reproduction.
        Eur J Obstet Gynecol Reprod Biol. 2011; 159: 267-272
      1. Higgins J, Green S, eds. Cochrane handbook for systematic reviews of interventions, version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from

        • Guyatt G.
        • Oxman A.D.
        • Akl E.A.
        • Kunz R.
        • Vist G.
        • Brozek J.
        • et al.
        GRADE guidelines. I. Introduction—GRADE evidence profiles and summary of findings tables.
        J Clin Epidemiol. 2011; 64: 383-394
        • Batioglu A.S.
        • Sahin U.
        • Gurlek B.
        • Ozturk N.
        • Unsal E.
        The efficacy of melatonin administration on oocyte quality.
        Gynecol Endocrinol. 2012; 28: 91-93
        • Eryilmaz O.G.
        • Devran A.
        • Sarikaya E.
        • Aksakal F.N.
        • Mollamahmutoglu L.
        • Cicek N.
        Melatonin improves the oocyte and the embryo in IVF patients with sleep disturbances, but does not improve the sleeping problems.
        J Assist Reprod Genet. 2011; 28: 815-820
        • Rizzo P.
        • Raffone E.
        • Benedetto V.
        Effect of the treatment with myo-inositol plus folic acid plus melatonin in comparison with a treatment with myo-inositol plus folic acid on oocyte quality and pregnancy outcome in IVF cycles. A prospective, clinical trial.
        Eur Rev Med Pharmacol Sci. 2010; 14: 555-561
        • Nazzaro A.
        • Salermo A.
        • Marino S.
        • Granato C.
        • Pastore E.
        The addiction of melatonin to myo-inositol plus folic acid improve oocyte quality and pregnancy outcome in IVF cycle. A prospective clinical trial.
        Hum Reprod. 2011; 26: i227-i228
        • Pacchiarotti A.
        • Carlomagno G.
        • Unfer V.
        • Frati P.
        • Pacchiarotti A.
        • Prapas N.
        • et al.
        Role of myo-inositol and melatonin supplementation in follicular fluid of IVF patients with polycystic ovarian syndrome: a randomized controlled trial.
        ClinicalTrialsgov. 2013; (NCT01540747)
        • Tamura H.
        • Takasaki A.
        • Miwa I.
        • Taniguchi K.
        • Maekawa R.
        • Asada H.
        • et al.
        Oxidative stress impairs oocyte quality and melatonin protects oocytes from free radical damage and improves fertilization rate.
        J Pineal Res. 2008; 44: 280-287
        • Showell M.G.
        • Brown J.
        • Clarke J.
        • Hart R.J.
        Antioxidants for female subfertility.
        Cochrane Database Syst Rev. 2013; 8 (CD007807)